Cargando…
Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modified mesoporous silica
Targeted delivery of antitumor drugs has been recognized as a promising therapeutic modality to improve treatment efficacy, reduce the toxic side effects and inhibit tumor recurrence. In this study, based on the high biocompatibility, large specific surface area, and easy surface modification of sma...
Autores principales: | Wang, Xinglong, Li, Gongke, Li, Ke, Shi, Yu, Lin, Wenzheng, Pan, Chun, Li, Dandan, Chen, Hao, Du, Jianwei, Wang, Huihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978000/ https://www.ncbi.nlm.nih.gov/pubmed/36873361 http://dx.doi.org/10.3389/fbioe.2023.1135655 |
Ejemplares similares
-
Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
por: Wu, Han, et al.
Publicado: (2021) -
Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy
por: Chaudhary, Zanib, et al.
Publicado: (2019) -
Efficient Photoacoustic Imaging With Biomimetic Mesoporous Silica-Based Nanoparticles
por: Huang, Chuangjia, et al.
Publicado: (2021) -
Modified hollow mesoporous silica nanoparticles as immune adjuvant-nanocarriers for photodynamically enhanced cancer immunotherapy
por: Li, Qianru, et al.
Publicado: (2022) -
Preparation and Characterization of Vancomycin Hydrochloride-Loaded Mesoporous Silica Composite Hydrogels
por: Sun, Ming, et al.
Publicado: (2022)